UCSF-Proctor Clinician Vision Scholars K12 Program
UCSF-Proctor 临床医生视力学者 K12 计划
基本信息
- 批准号:10610924
- 负责人:
- 金额:$ 53.14万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-05-01 至 2025-04-30
- 项目状态:未结题
- 来源:
- 关键词:Advisory CommitteesAppointmentBiomedical EngineeringBlindnessCareer MobilityClinical SciencesCollaborationsCommunicationDevelopmentEpidemiologyFacultyFundingGeneticGrantHealthHealth SciencesHumanInjuryInstitutionInvestigationLeadershipMentored Clinical Scientist Development ProgramMentorsMentorshipMethodologyMonitorNatural regenerationNerve DegenerationOphthalmologyOralOutcomeProgram EvaluationRecordsReproducibilityResearchResearch PersonnelScienceScientistStrategic PlanningStructureTalentsTherapeuticTimeTrainingTranslational ResearchVisionVisual SystemWorkWritingcareercareer developmentdidactic educationglobal healthimprovedinnovationprogramsrandomized, clinical trialsresearch and developmentresponsible research conductskillssuccessvision science
项目摘要
PROJECT SUMMARY/ABSTRACT
We propose the establishment of a UCSF-Proctor Clinician Vision Scholars K12 program for the mentoring and
training of talented and diverse faculty Scholars in high quality, reproducible scientific research and the
development of successful academic careers in ophthalmology and vision sciences. UCSF is one of the world’s
leading health sciences institutions and this program will build on existing strengths in clinical and translational
sciences, bioengineering, and career development. The objectives of the program are to 1) mentor and train
exceptional and diverse junior faculty in developing methodological expertise and impactful research programs;
and 2) transition the K12 Scholars to become independent investigators and successful academic careers. Two
clinician-scientists with complementary scientific expertise and leadership skills will co-direct the program. An
accomplished group of Mentors with broad expertise and strong records of mentorship and collaboration will
provide the Scholars with structured mentorship across three Tracks. Track 1 is focused on
epidemiology/randomized clinical trials/global health, Track 2 on basic and translational discovery science,
specifically around the themes of ocular genetics & therapeutics, visual system injury, plasticity, & regeneration,
and neurodegeneration, and Track 3 on bioengineering and innovation investigations. Key activities in the
training plan include: 1) high-quality mentored research; 2) a customized didactic curriculum tailored to the Track;
3) career development and academic success skills; 4) detailed plan for transition to independence; and 5)
training in the responsible conduct of research. The career development and transition to independence activities
emphasize oral and written communication, grant writing, leadership, networking, responsible conduct of
research, and scientific management skills. An Advisory Committee will work with the program directors to select
K12 Scholars, monitor their progress, and identify opportunities for program quality improvement. An External
Advisory Board will also provide input on program evaluation and strategic planning. The planned duration of
appointments is three years and the projected number of junior faculty Scholars is two training at any given time.
The intended outcomes for Scholars are engagement in rigorous, reproducible research, the development of
funded independent ophthalmology and vision science research programs with a lasting impact on the field and
a focus on improving human health and alleviating blindness, and the advancement of successful academic
careers as leaders and mentors in the field.
项目概要/摘要
我们建议建立 UCSF-Proctor Clinician Vision Scholars K12 计划,用于指导和
培养才华横溢、多元化的教师学者,进行高质量、可重复的科学研究和
加州大学旧金山分校在眼科和视觉科学领域取得了成功的学术生涯,是世界上最成功的大学之一。
领先的健康科学机构,该计划将建立在临床和转化方面的现有优势之上
该计划的目标是 1) 指导和培训。
在发展方法论专业知识和有影响力的研究项目方面表现出色且多样化的初级教师;
2) 将 K12 学者转变为独立研究者并取得成功的学术生涯。
具有互补科学专业知识和领导能力的临床医生科学家将共同指导该计划。
由具有广泛专业知识和良好指导与合作记录的导师组成的团队将
为学者提供跨三个轨道的结构化指导,轨道 1 的重点是。
流行病学/随机临床试验/全球健康,第二轨基础和转化发现科学,
特别是围绕眼遗传学和治疗、视觉系统损伤、可塑性和再生等主题,
和神经退行性疾病,以及生物工程和创新研究的关键活动 3。
培训计划包括:1)高质量的指导研究;2)针对该轨道量身定制的教学课程;
3) 职业发展和学业成功技能;4) 向独立过渡的详细计划;
负责任地进行研究的培训。职业发展和向独立活动的过渡。
强调口头和书面沟通、拨款写作、领导力、网络、负责任的行为
咨询委员会将与项目主管合作选择。
K12 学者,监控他们的进度,并确定项目质量改进的机会。
咨询委员会还将就计划评估和战略规划提供意见。
任命期限为三年,预计初级教员学者的人数为在任何特定时间接受两次培训。
学者们的预期成果是参与严格的、可重复的研究、开发
资助独立的眼科和视觉科学研究项目,对该领域产生持久影响,
专注于改善人类健康和减轻失明以及促进成功的学术进步
作为该领域的领导者和导师。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
THOMAS M LIETMAN其他文献
THOMAS M LIETMAN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('THOMAS M LIETMAN', 18)}}的其他基金
Azithromycin Reduction to Reach Elimination of Trachoma
减少阿奇霉素以消除沙眼
- 批准号:
10439385 - 财政年份:2020
- 资助金额:
$ 53.14万 - 项目类别:
Azithromycin Reduction to Reach Elimination of Trachoma
减少阿奇霉素以消除沙眼
- 批准号:
10616840 - 财政年份:2020
- 资助金额:
$ 53.14万 - 项目类别:
Azithromycin Reduction to Reach Elimination of Trachoma
减少阿奇霉素以消除沙眼
- 批准号:
10397057 - 财政年份:2020
- 资助金额:
$ 53.14万 - 项目类别:
UCSF-Proctor Clinician Vision Scholars K12 Program
UCSF-Proctor 临床医生视力学者 K12 计划
- 批准号:
10409646 - 财政年份:2020
- 资助金额:
$ 53.14万 - 项目类别:
Azithromycin Reduction to Reach Elimination of Trachoma
减少阿奇霉素以消除沙眼
- 批准号:
10907941 - 财政年份:2020
- 资助金额:
$ 53.14万 - 项目类别:
Azithromycin Reduction to Reach Elimination of Trachoma
减少阿奇霉素以消除沙眼
- 批准号:
10618166 - 财政年份:2020
- 资助金额:
$ 53.14万 - 项目类别:
Steroids and Cross-linking for Ulcer Treatment (SCUT II)
类固醇和交联治疗溃疡 (SCUT II)
- 批准号:
10397960 - 财政年份:2019
- 资助金额:
$ 53.14万 - 项目类别:
Steroids and Cross-linking for Ulcer Treatment (SCUT II)
类固醇和交联治疗溃疡 (SCUT II)
- 批准号:
10457913 - 财政年份:2019
- 资助金额:
$ 53.14万 - 项目类别:
Steroids and Cross-linking for Ulcer Treatment (SCUT II)
类固醇和交联治疗溃疡 (SCUT II)
- 批准号:
10222699 - 财政年份:2019
- 资助金额:
$ 53.14万 - 项目类别:
Steroids and Cross-linking for Ulcer Treatment (SCUT II)
类固醇和交联治疗溃疡 (SCUT II)
- 批准号:
10666415 - 财政年份:2019
- 资助金额:
$ 53.14万 - 项目类别:
相似国自然基金
面向集卡预约环境的港口集疏运道路作业计划与管控方法
- 批准号:52372303
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
面向一站式预约的门诊患者多检查动态调度优化研究
- 批准号:72371200
- 批准年份:2023
- 资助金额:41 万元
- 项目类别:面上项目
基于集卡预约扰动致因解构的港口集疏运通道空间尺度优化研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
考虑患者等待时长的医疗系统预约调度研究:基于近似动态规划的方法
- 批准号:72272027
- 批准年份:2022
- 资助金额:45 万元
- 项目类别:面上项目
数据驱动下港口集卡预约系统的预约配额方案优化与失约车辆再预约策略研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
UCSF-Proctor Clinician Vision Scholars K12 Program
UCSF-Proctor 临床医生视力学者 K12 计划
- 批准号:
10409646 - 财政年份:2020
- 资助金额:
$ 53.14万 - 项目类别:
Administration - Resource for Molecular Imaging Agents in Precision Medicine
管理 - 精准医学中分子成像剂的资源
- 批准号:
10226207 - 财政年份:2017
- 资助金额:
$ 53.14万 - 项目类别:
Sources, Transport, Exposure and Effects of PFASs (STEEP)
PFAS 的来源、传输、暴露和影响 (STEEP)
- 批准号:
9258539 - 财政年份:2017
- 资助金额:
$ 53.14万 - 项目类别: